TB notification in Hong Kong

Slides:



Advertisements
Similar presentations
TB and poverty agenda in WPR WHO/WPRO Stop TB. World Health Organization Percentage of population living below US$1 a day.
Advertisements

National TB Program Indonesia 1 TB Epidemic DOTS HIV Epidemic.
Enhancing HIV/AIDS Surveillance in California California Department of Public Health Office of AIDS Guide for Health Care Providers.
Tuberculosis in the UK 2013 report
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Control of Tuberculosis in Australia Guy B. Marks Woolcock Institute of Medical Research Department of Respiratory Medicine, Liverpool Hospital.
Three key messages on tuberculosis control World Tuberculosis Day 2010 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Experiences in Tanzania: Community Based Efforts to Support HIV/TB Integration Jackson Mugyabuso Dr. Charlotte Colvin PATH 25 July 2012.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Challenges and Constraints for TB Control in Kenya Dr. James Nyikal Director of Medical Services, Kenya.
TB: Can we end it as AIDS in the future? Presentation for discussion RIHES December 9, 2015.
Did we reach the 2005 targets? Will we achieve the Millennium Development Goals?
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
UK Renal Registry 13th Annual Report
Instructional Objectives:
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
Nim Arinaminpathy Imperial College London IDM Symposium, 20 Apr 2017
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration  Alasdair Reid, MD, Fabio Scano,
The Incidence of AIDS-related Diseases and HIV-Infection Control in the Republic of Komi V.M. Chzhao State Establishment “The Republican Centre for.
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
TB- HIV Collaborative activities in Romania- may 2006 status
Comparison of three Observational Analytical strategies
Philippe Glaziou Geneva, 12 October 2009
Relative Values.
Table 1 Characteristics of study population, by pneumococcal vaccination status. From: Prior Pneumococcal Vaccination Is Associated with Reduced Death,
Rational Use of ARV Medicines
R Nagar 1, Debashish Kundu2, S Chandra2 , A Khanna1
Zaw Win, Tin Aung, Sun Tun Population Services International/ Myanmar
Influenza Vaccine Effectiveness Against Pediatric Deaths:
PROGRESS IN GLOBAL TB CONTROL
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
ДЭМБ, Сүрьеэтэй тэмцэх стратеги он: Бүсийн хэтийн төлөвлөгөө
TUBERCULOSIS SURVEILLENCE KENYA
Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea
UK Renal Registry 16th Annual Report
Four indirect measures of TB incidence
Direct estimates of the burden of disease EURO Workshop November 2003
Review of Wednesday 5th May
National Prevalence Survey, Cambodia
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
Cheng shiming National TB Center in China May,3, 2004
Sample size.
Measures of risk and association
Surveys of TB infection and disease
Four indirect measures of TB incidence
TB epidemiology in Bulgaria
Epidemiology of Tuberculosis in Hong Kong
PROGRESS IN GLOBAL TB CONTROL
M Javanbakht, S Guerry, LV Smith, P Kerndt
Huang Fei National center for TB control and prevention, China
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
UK Renal Registry 15th Annual Report
UK Renal Registry 14th Annual Report
Four indirect measures of TB incidence
Issues on the current information system
Further explorations of surveillance data
Country presentation Dr.Vija Riekstina National TB registry
Further explorations of surveillance data
Surveillance, Monitoring and Evaluation Working Group
Opportunities for a chronic disease outreach program in China
Background & rational DEWG meeting 2009
Further explorations of surveillance data
TRACE INITIATIVE: Overview
The Number of Adults Reporting Not Getting Needed Care Because of Cost Declined in 2014 for the First Time Since 2003 Percent of adults ages 19–
Abstract Problem Statement: Armenia received anti-TB drugs from the Global Drug Facility to treat patients in the civil sector in January 2003, whereas.
Presentation transcript:

TB notification in Hong Kong Year Notification rate per 100,000 Rate of decline 1951 689 1961 397 5.4% 1971 223 5.6% 1981 149 4.0% 1991 109 3.1% 2002 97

Estimates on TB incidence and prevalence No prevalence surveys Indirect estimates only Incidence rate about 140/100,000 and 120/100,000 for year 1999 and 2002 assuming 80% cases detected Prevalence rate: ?240/100,000 if each case of bacillary TB last for two years (??over-estimate)

Case detection rate DOTS case detection rate: 56% (1999) and 51% (2002) (WHO figures) Proportion of TB patients seeking medical care from private sector unknown Average age SS +ve over 50 More and more reactivation case Difficult to separate out effect of aging

The way forward ? Examine the relative importance of endogenous reactivation and recent transmission as a cause of disease ? Enhanced communication with private doctors for better case detection and tracking of treatment outcome ? Cohort studies/ ? Prevalence surveys of disease and infection